Filing search / VBI Vaccines Inc / "Tax"

8-K

EX-1.1

VBIVQ VBI Vaccines Inc

15 May 24

VBI Vaccines Reports First Quarter 2024 Financial Results

4:18pm

is in default with respect to any Indebtedness. (ff) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably … income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid

8-K

EX-99.1

VBIVQ VBI Vaccines Inc

15 May 24

VBI Vaccines Reports First Quarter 2024 Financial Results

4:18pm

income Foreign exchange loss Loss before income taxes Income tax benefit Net Loss Basic and diluted net loss per share Weighted-average number

424B5

VBIVQ VBI Vaccines Inc

15 May 24

Prospectus supplement for primary offering

4:16pm

OF PROCEEDS S-10 DILUTION S-11 PLAN OF DISTRIBUTION S-12 MATERIAL UNITED STATES INCOME TAX CONSIDERATIONS S-13 MATERIAL Canadian Federal Income Tax … result in adverse U.S. federal income tax consequences to U.S. Holders of our common shares. A non-U.S. corporation, such as us, would be classified

8-K

EX-99.1

zoge1toxplq1y1

16 Apr 24

VBI Vaccines Reports Full Year 2023 Financial Results

8:00am

8-K

EX-4.2

k6qt4mc2jyfnkj

11 Apr 24

VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

4:07pm

8-K

EX-4.1

hbce2ao1

11 Apr 24

VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

4:07pm

8-K

EX-10.1

8q2tech

11 Apr 24

VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

4:07pm

424B5

txoqkyd

11 Apr 24

Prospectus supplement for primary offering

9:06am

8-K

EX-99.1

mrclxy vv

14 Nov 23

VBI Vaccines Reports Third Quarter 2023 Financial Results

4:07pm

8-K

EX-99.1

1hiupc9urh

14 Aug 23

VBI Vaccines Reports Second Quarter 2023 Financial Results

8:00am